Renal receptors for calcitonin. Binding and degradation of hormone.

Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest (1986) 1.73

Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem J (1988) 1.14

Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration. J Am Soc Nephrol (2010) 1.05

Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat. J Cell Biol (1980) 1.03

Distribution of calcitonin-sensitive adenylate cyclase activity along the rabbit kidney tubule. Proc Natl Acad Sci U S A (1976) 0.97

New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells. Am J Physiol Cell Physiol (2012) 0.92

Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D). Biochem J (1981) 0.89

Characterization of specific receptors for calcitonin in porcine lung. Proc Natl Acad Sci U S A (1981) 0.88

Hydrolysis of an exogenous 125I-labelled protein by rat yolk sacs. Evidence for intracellular degradation within lysosomes. Biochem J (1979) 0.86

Calcitonin-sensitive adenylate cyclase in rat renal tubular membranes. Biochem J (1975) 0.81

Human placental calcitonin receptors. Biochem J (1988) 0.80

Physician resource databank: numbers, distribution and activities of Canada's physicians. Can Med Assoc J (1985) 9.66

Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95

Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design. Protein Sci (1998) 7.03

Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12

The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) (1981) 5.29

Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat. J Biol Chem (1971) 5.25

Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab (1971) 5.20

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13

Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate. Methods Enzymol (1974) 3.50

Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone. J Clin Invest (1969) 3.41

Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A (1996) 3.39

IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE. Proc Natl Acad Sci U S A (1963) 3.31

A link between mRNA turnover and RNA interference in Arabidopsis. Science (2004) 3.22

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell (1999) 3.16

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07

Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science (1968) 2.90

Medical-legal concerns among Canadian anaesthetists. Can J Anaesth (1990) 2.82

Parathyroid function and the renal excretion of 3'5'-adenylic acid. Proc Natl Acad Sci U S A (1967) 2.81

alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem (2001) 2.77

Hydrogen exchange and the dynamic structure of proteins. Mol Cell Biochem (1982) 2.74

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69

A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A (2001) 2.57

Determination of 3',5'-adenosine monophosphate with a method based on a radioactive phosphate exchange reaction. J Biol Chem (1968) 2.47

Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A (1998) 2.39

Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem (1987) 2.38

Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology (1968) 2.36

Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22

One hospital's experience with a "Do not resuscitate" policy. Can Med Assoc J (1981) 2.20

Clonal rat parathyroid cell line expresses a parathyroid hormone-related peptide but not parathyroid hormone itself. Biochem Biophys Res Commun (1989) 2.15

Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med (1983) 2.14

Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab (1967) 2.00

Isolation and chemical properties of porcine parathyroid hormone. Biochemistry (1971) 1.92

Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet (1997) 1.90

Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res (1997) 1.82

A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res (1997) 1.82

The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care (2000) 1.81

Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet (1997) 1.77

Parathyroid hormone: chemical properties and structural requirements for biological and immunological activity. Recent Prog Horm Res (1966) 1.74

Plasma membrane protein subunit composition. A comparative study by discontinuous electrophoresis in sodium dodecyl sulfate. J Biol Chem (1971) 1.74

Evaluation by radioimmunoassay of factors controlling the secretion of parathyroid hormone. Nature (1966) 1.71

Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci (1996) 1.71

The hydrogen exchange core and protein folding. Protein Sci (1999) 1.71

Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70

Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med (1974) 1.69

The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene (2001) 1.69

Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci (1998) 1.69

Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site. Science (1974) 1.68

Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. Endocrinology (1969) 1.65

Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity. Endocrinology (1973) 1.65

Primary hyperparathyroidism: clinical and biochemical features. Medicine (Baltimore) (1974) 1.63

Bioassay of parathyroid hormone in vitro with a stable preparation of adenyl cyclase from rat kidney. Endocrinology (1969) 1.62

Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61

Assay for calcium channels. Methods Enzymol (1985) 1.60

Structure of form III crystals of bovine pancreatic trypsin inhibitor. J Mol Biol (1987) 1.58

The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro. J Biol Chem (1970) 1.58

Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann Surg (1992) 1.57

Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab (1998) 1.56

Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. J Mol Biol (2003) 1.56

Protein internal flexibility and global stability: effect of urea on hydrogen exchange rates of bovine pancreatic trypsin inhibitor. Biochemistry (1993) 1.56

7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest (2001) 1.55

Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun (1980) 1.54

Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol (1997) 1.53

Parathyroid hormone: sequence, synthesis, immunoassay studies. Am J Med (1971) 1.53

Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc Natl Acad Sci U S A (1971) 1.50

Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci U S A (1998) 1.49

Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat Genet (1999) 1.47

Parathyroid adenomas in the aortopulmonary window. Radiology (1996) 1.46

Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron (1996) 1.46

Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis (2001) 1.46

Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem (1998) 1.44

FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab (2004) 1.43

Pseudohypoparathyroidism: the molecular basis for hormone resistance--a retrospective. N Engl J Med (1982) 1.42

Parathyroid hormone-sensitive adenyl cyclase in isolated renal tubules. Endocrinology (1970) 1.41

A survey of postgraduate training for family practice. Can Med Assoc J (1985) 1.41

Fluoride stimulation of adenylate cyclase is dependent on the guanine nucleotide regulatory protein. J Biol Chem (1980) 1.40

Influence of companion animals on the physical and psychological health of older people: an analysis of a one-year longitudinal study. J Am Geriatr Soc (1999) 1.39

Extended-wear Hydrocurve and Sauflon contact lenses. Am J Ophthalmol (1980) 1.39

Use of unlicensed nitric oxide in Austria. Lancet (1997) 1.38

The conserved, buried aspartic acid in oxidized Escherichia coli thioredoxin has a pKa of 7.5. Its titration produces a related shift in global stability. Biochemistry (1991) 1.38

Tyrosine aminotransferase: enzyme induction independent of adenosine 3', 5'-monophosphate. Science (1968) 1.37

Evidence of multiple receptor sites within the putative calcium channel. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.37

Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med (1980) 1.37

The amino-acid sequence of the amino-terminal 37 residues of human parathyroid hormone. Proc Natl Acad Sci U S A (1974) 1.37

Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab (2001) 1.36

Role of anions in parathyroid hormone release from dispersed bovine parathyroid cells. Proc Natl Acad Sci U S A (1978) 1.36

Aspiration of enlarged parathyroid glands for parathyroid hormone assay. Radiology (1983) 1.34

Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab (1978) 1.33

An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med (1982) 1.33

Reoperative parathyroid surgery for persistent hyperparathyroidism. Surgery (1978) 1.32

Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med (1978) 1.32